Advancis Likely To Change Name Following Ruling In Favor Of Sanofi-Aventis
This article was originally published in The Pink Sheet Daily
Executive Summary
Court rules that Advancis name infringes on Sanofi-Aventis' trademark and orders the two firms to submit a proposed order by Oct. 23.
You may also be interested in...
MiddleBrook Aims To Address $600 Million Strep Market With Moxatag
Company plans to launch the first once-daily amoxicillin formulation for patients over 12 in the fall.
MiddleBrook Aims To Address $600 Million Strep Market With Moxatag
Company plans to launch the first once-daily amoxicillin formulation for patients over 12 in the fall.
Advancis Gets “Refuse To File” Letter For Pulsatile Amoxicillin NDA
Firm may need to manufacture commercial-sized quantities of antibiotic in order for FDA to accept the submission.